Status and phase
Conditions
Treatments
About
The purpose of this study is to is to determine the clinical effectiveness of a single dose of intravenous (IV) medication for the prevention of labor arrest and cesarean delivery in primiparous women undergoing trial of labor.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Primiparous
Viable single intrauterine pregnancy
-≥ 34 weeks of gestation
Ruptured membranes
Category I tracing at time of inclusion
Active phase of labor (>=6 cm of cervix dilation)
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
200 participants in 2 patient groups
Loading...
Central trial contact
Samantha Antonioli, MD; Aaron Roberts
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal